← Evidence map

ArticleBMC cancer2019

Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?

Didar Yanardag Acik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31718601